Interclean Shanghai

Accuray and IMPAC to link CyberKnife Robotic Radiosurgery System

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...
Accuray Incorporated and IMPAC Medical Systems, Inc. announced that they will collaborate to develop inter-operability between the CyberKnife® Robotic Radiosurgery System and the  MOSAIQ® oncology information system. Using DICOM standard interface protocols, both treatment plan and delivery information from the CyberKnife System will automatically feed directly into the IMPAC electronic medical record.

Accuray Incorporated and IMPAC Medical Systems, Inc. announced that they will collaborate to develop inter-operability between the CyberKnife® Robotic Radiosurgery System and the  MOSAIQ® oncology information system. Using DICOM standard interface protocols, both treatment plan and delivery information from the CyberKnife System will automatically feed directly into the IMPAC electronic medical record.

Centralization of patient oncology data into a single, easily-accessible location is essential for state-of-the-art cancer care.  With this capability, clinicians will have all necessary information readily available to make timely and informed medical decisions.

The CyberKnife System produces unique treatment records that are a vital element to the comprehensive patient chart. MOSAIQ’s electronic data exchange automatically coordinates with the CyberKnife System, eliminating the need for manual data entry.

Euan S. Thomson, Ph.D., president and CEO of Accuray Incorporated said, We were pleased to partner with IMPAC on this project. The majority of our CyberKnife customers utilize IMPAC’s oncology information system to manage their departments and patient records. This collaboration provides considerable value to our mutual customers, not only saving them time and effort, but also ensuring high-quality care

Jay Hoey, president and CEO of IMPAC Medical Systems said, Since 1990, IMPAC has remained committed to vendor independent connectivity, enabling cancer centers to integrate data from various treatment delivery systems regardless of manufacturer. This solution represents our continued dedication to the open-systems initiatives as outlined by IHE-RO.

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »